Rivian (RIVN) Price Target Reaffirmed — Here’s What Analysts See

Rivian Automotive, Inc. (NASDAQ:RIVN) is one of the AI Stocks Analysts Say You Shouldn’t Ignore. On August 25, Needham analyst Chris Pierce reiterated a Buy rating on the stock with a $14.00 price target. The rating affirmation comes ahead of the company’s R2 launch supported by end-market diligence and a consumer survey.

According to the firm, the R2 is Rivian’s mid-size SUV with an approximate $50,000 average selling price. This vehicle has the potential to expand the company’s total addressable market beyond the company’s expensive R1 vehicle.

“We reiterate our Buy rating and $14 target ahead of RIVN’s R2 launch, supported by end-market diligence and a consumer survey conducted in low EV penetration metros. The R2 is RIVN’s ~$50k ASP mid-size SUV, substantially expanding RIVN’s TAM beyond the more expensive R1 vehicle.”

Rivian (RIVN) Price Target Reaffirmed — Here’s What Analysts See

“The size of the potential market opportunity for the R2 is encouraging when looking across current EV and ICE offerings at similar price points, and even more so vs modest consensus FY26 R2 delivery estimates. Our survey work found strong RIVN brand awareness, limited negative perception and encouraging purchase intent, positioning RIVN favorably to capture share as the R2 enters the mid-size SUV segment. Our $14 price target represents 15x EV/our FY28E adj EBITDA discounted back.”

Rivian Automotive, Inc. (NASDAQ:RIVN) is an automaker that creates and manufactures electric vehicles, as well as software and services.

While we acknowledge the risk and potential of RIVN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RIVN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Must-Watch AI Stocks for Investors and 10 AI Stocks Hit with New Analyst Ratings

Disclosure: None.